Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2009

Open Access 01-12-2009 | Research article

Exhaled nitric oxide and airway hyperresponsiveness in workers: a preliminary study in lifeguards

Authors: Valérie Demange, Abraham Bohadana, Nicole Massin, Pascal Wild

Published in: BMC Pulmonary Medicine | Issue 1/2009

Login to get access

Abstract

Background

Airway inflammation and airway hyperresponsiveness (AHR) are two characteristic features of asthma. Fractional exhaled nitric oxide (FENO) has shown good correlation with AHR in asthmatics. Less information is available about FENO as a marker of inflammation from work exposures. We thus examined the relation between FENO and AHR in lifeguards undergoing exposure to chloramines in indoor pools.

Methods

39 lifeguards at six indoor pools were given a respiratory health questionnaire, FENO measurements, spirometry, and a methacholine bronchial challenge (MBC) test. Subjects were labeled MBC+ if the forced expiratory volume (FEV1) fell by 20% or more. The normalized linear dose-response slope (NDRS) was calculated as the percentage fall in FEV1 at the last dose divided by the total dose given. The relation between MBC and FENO was assessed using logistic regression adjusting on confounding factors. The association between NDRS and log-transformed values of FENO was tested in a multiple linear regression model.

Results

The prevalence of lifeguards MBC+ was 37.5%. In reactors, the median FENO was 18.9 ppb (90% of the predicted value) vs. 12.5 ppb (73% predicted) in non-reactors. FENO values ≥ 60% of predicted values were 80% sensitive and 42% specific to identify subjects MBC+. In the logistic regression model no other factor had an effect on MBC after adjusting for FENO. In the linear regression model, NDRS was significantly predicted by log FENO.

Conclusions

In lifeguards working in indoor swimming pools, elevated FENO levels are associated with increased airway responsiveness.
Appendix
Available only for authorised users
Literature
1.
go back to reference Busse WW, Rosenwasser LJ: Mechanisms of asthma. J Allergy Clin Immunol. 2003, 111 (Suppl 3): 799-804. 10.1067/mai.2003.158.CrossRef Busse WW, Rosenwasser LJ: Mechanisms of asthma. J Allergy Clin Immunol. 2003, 111 (Suppl 3): 799-804. 10.1067/mai.2003.158.CrossRef
2.
go back to reference Brutsche MH, Downs SH, Schindler C, Gerbase MW, Schwartz J, Frey M, Russi EW, Ackermann-Liebrich U, Leuenberger P, SAPALDIA Team: Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA Cohort Study. Thorax. 2006, 61: 671-677. 10.1136/thx.2005.052241.CrossRefPubMedPubMedCentral Brutsche MH, Downs SH, Schindler C, Gerbase MW, Schwartz J, Frey M, Russi EW, Ackermann-Liebrich U, Leuenberger P, SAPALDIA Team: Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA Cohort Study. Thorax. 2006, 61: 671-677. 10.1136/thx.2005.052241.CrossRefPubMedPubMedCentral
3.
go back to reference Boutet K, Malo JL, Ghezzo H, Gautrin D: Airway hyperresponsiveness and risk of chest symptoms in an occupational model. Thorax. 2007, 62: 260-264. 10.1136/thx.2005.056333.CrossRefPubMed Boutet K, Malo JL, Ghezzo H, Gautrin D: Airway hyperresponsiveness and risk of chest symptoms in an occupational model. Thorax. 2007, 62: 260-264. 10.1136/thx.2005.056333.CrossRefPubMed
4.
go back to reference Alving K, Weitzberg E, Lundberg JM: Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J. 1993, 6: 1368-1370.PubMed Alving K, Weitzberg E, Lundberg JM: Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J. 1993, 6: 1368-1370.PubMed
5.
go back to reference Smith A, Cowan J, Filsell S, McLachlan C, Monti-Sheehan G, Jackson P, Taylor RD: Diagnosing asthma. Comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med. 2004, 169: 473-478. 10.1164/rccm.200310-1376OC.CrossRefPubMed Smith A, Cowan J, Filsell S, McLachlan C, Monti-Sheehan G, Jackson P, Taylor RD: Diagnosing asthma. Comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med. 2004, 169: 473-478. 10.1164/rccm.200310-1376OC.CrossRefPubMed
6.
go back to reference Kharitonov SA, Yates DH, Barnes PJ: Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med. 1996, 153: 454-457.CrossRefPubMed Kharitonov SA, Yates DH, Barnes PJ: Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med. 1996, 153: 454-457.CrossRefPubMed
7.
go back to reference Bohadana AB, Michaely JP, Teculescu D, Wild P: Reproducibility of exhaled nitric oxide in smokers and non-smokers: relevance for longitudinal studies. BMC Pulm Med. 2008, 8: 4-10.1186/1471-2466-8-4.CrossRefPubMedPubMedCentral Bohadana AB, Michaely JP, Teculescu D, Wild P: Reproducibility of exhaled nitric oxide in smokers and non-smokers: relevance for longitudinal studies. BMC Pulm Med. 2008, 8: 4-10.1186/1471-2466-8-4.CrossRefPubMedPubMedCentral
8.
go back to reference Lund MB, Oksne PI, Hamre R, Kongerud J: Increased nitric oxide in exhaled air: an early marker of asthma in non-smoking aluminium potroom workers?. Occup Envir Med. 2000, 57: 274-278. 10.1136/oem.57.4.274.CrossRef Lund MB, Oksne PI, Hamre R, Kongerud J: Increased nitric oxide in exhaled air: an early marker of asthma in non-smoking aluminium potroom workers?. Occup Envir Med. 2000, 57: 274-278. 10.1136/oem.57.4.274.CrossRef
9.
go back to reference Ulvestad B, Lund MB, Bakke B, Djupesland PG, Kongerud J, Boe J: Gans and dust exposure in underground construction is associated with signs of airway inflammation. Eur Respir J. 2001, 17: 416-421. 10.1183/09031936.01.17304160.CrossRefPubMed Ulvestad B, Lund MB, Bakke B, Djupesland PG, Kongerud J, Boe J: Gans and dust exposure in underground construction is associated with signs of airway inflammation. Eur Respir J. 2001, 17: 416-421. 10.1183/09031936.01.17304160.CrossRefPubMed
10.
go back to reference Maniscalco M, Grieco L, Galdi A, Lundberg JO, Sofia M: Increase in exhaled nitric oxide in shoe and leather workers at the end of the work-shift. Occup Med (Lond). 2004, 54: 404-407. 10.1093/occmed/kqh082.CrossRef Maniscalco M, Grieco L, Galdi A, Lundberg JO, Sofia M: Increase in exhaled nitric oxide in shoe and leather workers at the end of the work-shift. Occup Med (Lond). 2004, 54: 404-407. 10.1093/occmed/kqh082.CrossRef
11.
go back to reference Olin AC, Alving K, Toren K: Exhaled nitric oxide: relation to sensitization and respiratory symptoms. Clin Exp Allergy. 2004, 34: 221-226. 10.1111/j.1365-2222.2004.01888.x.CrossRefPubMed Olin AC, Alving K, Toren K: Exhaled nitric oxide: relation to sensitization and respiratory symptoms. Clin Exp Allergy. 2004, 34: 221-226. 10.1111/j.1365-2222.2004.01888.x.CrossRefPubMed
12.
go back to reference Zietkowski Z, Bodzenta-Lukaszyk A, Tomasiak MM, Skiepko R, Szmitkowski M: Comparison of exhaled nitric oxide measurement with conventional tests in steroid-naïve asthma patients. J Investig Allergol Clin Immunol. 2006, 16: 239-246.PubMed Zietkowski Z, Bodzenta-Lukaszyk A, Tomasiak MM, Skiepko R, Szmitkowski M: Comparison of exhaled nitric oxide measurement with conventional tests in steroid-naïve asthma patients. J Investig Allergol Clin Immunol. 2006, 16: 239-246.PubMed
13.
go back to reference Toorn Van den LM, Prins JB, Overbeek SE, Hoogsteden HC, de Jongste JC: Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. Am J Respir Crit Care Med. 2000, 162: 953-957.CrossRef Toorn Van den LM, Prins JB, Overbeek SE, Hoogsteden HC, de Jongste JC: Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. Am J Respir Crit Care Med. 2000, 162: 953-957.CrossRef
14.
go back to reference Franklin PJ, Stuck SM, Le Souëf PN, Ayres JG, Turner SW: Measuring exhaled nitric oxide levels in adults. The importance of atopy and airway responsiveness. Chest. 2004, 126: 1540-1545. 10.1378/chest.126.5.1540.CrossRefPubMed Franklin PJ, Stuck SM, Le Souëf PN, Ayres JG, Turner SW: Measuring exhaled nitric oxide levels in adults. The importance of atopy and airway responsiveness. Chest. 2004, 126: 1540-1545. 10.1378/chest.126.5.1540.CrossRefPubMed
15.
go back to reference Massin N, Bohadana AB, Wild P, Héry M, Toamain JP, Hubert G: Respiratory symptoms and bronchial responsiveness in lifeguards exposed to nitrogen trichloride in indoor swimming pools. Occup Environ Med. 1998, 55: 258-263. 10.1136/oem.55.4.258.CrossRefPubMedPubMedCentral Massin N, Bohadana AB, Wild P, Héry M, Toamain JP, Hubert G: Respiratory symptoms and bronchial responsiveness in lifeguards exposed to nitrogen trichloride in indoor swimming pools. Occup Environ Med. 1998, 55: 258-263. 10.1136/oem.55.4.258.CrossRefPubMedPubMedCentral
16.
go back to reference ATS/ERS: Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med. 2005, 171: 912-930. 10.1164/rccm.200406-710ST.CrossRef ATS/ERS: Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med. 2005, 171: 912-930. 10.1164/rccm.200406-710ST.CrossRef
17.
go back to reference Olin AC, Rosengren A, Thelle DS, Lissner L, Bake B, Toren K: Height, age and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest. 2006, 130: 1319-1325. 10.1378/chest.130.5.1319.CrossRefPubMed Olin AC, Rosengren A, Thelle DS, Lissner L, Bake B, Toren K: Height, age and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest. 2006, 130: 1319-1325. 10.1378/chest.130.5.1319.CrossRefPubMed
18.
go back to reference American Thoracic Society: Standardization of spirometry. Am J Respir Crit Care Med. 1995, 152: 1107-1136.CrossRef American Thoracic Society: Standardization of spirometry. Am J Respir Crit Care Med. 1995, 152: 1107-1136.CrossRef
19.
go back to reference American Thoracic Society: Guidelines for Methacholine and Exercise Challenge Testing- 1999. Am J Respir Crit Care Med. 2000, 161: 309-329.CrossRef American Thoracic Society: Guidelines for Methacholine and Exercise Challenge Testing- 1999. Am J Respir Crit Care Med. 2000, 161: 309-329.CrossRef
20.
go back to reference Cropp GJA, Bernstein IL, Boushey HA, Hyde RW, Rosenthal RR, Spector SL, Townley RG: Guidelines for bronchial inhalation challenges with pharmacologic and antigenic agents. ATS News. 1980, 11-19. Cropp GJA, Bernstein IL, Boushey HA, Hyde RW, Rosenthal RR, Spector SL, Townley RG: Guidelines for bronchial inhalation challenges with pharmacologic and antigenic agents. ATS News. 1980, 11-19.
21.
go back to reference O'Connor G, Sparrow D, Taylor D, Segal M, Weiss S: Analysis of dose-response curves to methacholine. An approach suitable for population studies. Am Rev Respir Dis. 1987, 128: 1412-1417.CrossRef O'Connor G, Sparrow D, Taylor D, Segal M, Weiss S: Analysis of dose-response curves to methacholine. An approach suitable for population studies. Am Rev Respir Dis. 1987, 128: 1412-1417.CrossRef
22.
go back to reference Bohadana AB, Massin N, Wild P, Kolopp MN, Toamain JP: Respiratory Symptoms and airway responsiveness in apparently healthy workers exposed to flour dust. Eur Respir J. 1994, 7: 1070-1076.PubMed Bohadana AB, Massin N, Wild P, Kolopp MN, Toamain JP: Respiratory Symptoms and airway responsiveness in apparently healthy workers exposed to flour dust. Eur Respir J. 1994, 7: 1070-1076.PubMed
23.
go back to reference Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V: Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med. 1998, 157: 4-9.CrossRefPubMed Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V: Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med. 1998, 157: 4-9.CrossRefPubMed
24.
go back to reference Kostikas K, Papaioannou AI, Tanou K, Koutsokera A, Papala M, Gourgoulianis KI: Portable exhaled nitric oxide as a screening tool for asthma in young adults during pollen season. Chest. 2008, 133: 906-913. 10.1378/chest.07-1561.CrossRefPubMed Kostikas K, Papaioannou AI, Tanou K, Koutsokera A, Papala M, Gourgoulianis KI: Portable exhaled nitric oxide as a screening tool for asthma in young adults during pollen season. Chest. 2008, 133: 906-913. 10.1378/chest.07-1561.CrossRefPubMed
25.
go back to reference Vergès S, Devouassoux G, Flore P, Rossini E, Fior-Gozlan M, Levy P, Wuyam B: Bronchial hyperresponsiveness, airway inflammation, and airflow limitation in endurance athletes. Chest. 2005, 127: 1935-1941. 10.1378/chest.127.6.1935.CrossRefPubMed Vergès S, Devouassoux G, Flore P, Rossini E, Fior-Gozlan M, Levy P, Wuyam B: Bronchial hyperresponsiveness, airway inflammation, and airflow limitation in endurance athletes. Chest. 2005, 127: 1935-1941. 10.1378/chest.127.6.1935.CrossRefPubMed
26.
go back to reference Ricciardolo FLM, Sterk PJ, Gaston B, Folkerts G: Nitric oxide in health and disease of the respiratory system. Physiol Rev. 2004, 84: 731-765. 10.1152/physrev.00034.2003.CrossRefPubMed Ricciardolo FLM, Sterk PJ, Gaston B, Folkerts G: Nitric oxide in health and disease of the respiratory system. Physiol Rev. 2004, 84: 731-765. 10.1152/physrev.00034.2003.CrossRefPubMed
27.
go back to reference Preller L, Doekes G, Heederik D, Vermeulen R, Vogelzang PF, Boleij JS: Disinfectant use as a risk factor for atopic sensitization and symptoms consistent of asthma: an epidemiological study. Eur Respir J. 1996, 9: 1407-1413. 10.1183/09031936.96.09071407.CrossRefPubMed Preller L, Doekes G, Heederik D, Vermeulen R, Vogelzang PF, Boleij JS: Disinfectant use as a risk factor for atopic sensitization and symptoms consistent of asthma: an epidemiological study. Eur Respir J. 1996, 9: 1407-1413. 10.1183/09031936.96.09071407.CrossRefPubMed
28.
go back to reference Franklin PJ, Turner SW, Le Souef PN, Stick SM: Exhaled nitric oxide and asthma: complex interactions between atopy, airway responsiveness, and symptoms in a community population of children. Thorax. 2003, 58: 1048-1052. 10.1136/thorax.58.12.1048.CrossRefPubMedPubMedCentral Franklin PJ, Turner SW, Le Souef PN, Stick SM: Exhaled nitric oxide and asthma: complex interactions between atopy, airway responsiveness, and symptoms in a community population of children. Thorax. 2003, 58: 1048-1052. 10.1136/thorax.58.12.1048.CrossRefPubMedPubMedCentral
29.
go back to reference De Zotti R, Bovenzi M: Prospective study of work related respiratory symptoms in trainee bakers. Occup Envir Med. 2000, 57: 58-61. 10.1136/oem.57.1.58.CrossRef De Zotti R, Bovenzi M: Prospective study of work related respiratory symptoms in trainee bakers. Occup Envir Med. 2000, 57: 58-61. 10.1136/oem.57.1.58.CrossRef
Metadata
Title
Exhaled nitric oxide and airway hyperresponsiveness in workers: a preliminary study in lifeguards
Authors
Valérie Demange
Abraham Bohadana
Nicole Massin
Pascal Wild
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2009
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-9-53

Other articles of this Issue 1/2009

BMC Pulmonary Medicine 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.